Literature DB >> 15037818

Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells.

Gu Kang1, Pil-Jae Kong, Young-Jin Yuh, So-Young Lim, Sung-Vin Yim, Wanjoo Chun, Sung-Soo Kim.   

Abstract

Inflammation is a significant component of chronic neurodegenerative diseases. Cyclooxygenase-2 (COX-2) is expressed in activated microglial cells and appears to be an important source of prostaglandins during inflammatory conditions. To investigate the effect of curcumin on COX-2 gene expression in microglial cells, we treated lipopolysaccharide (LPS)-challenged BV2 microglial cells with various concentrations of curcumin. Curcumin significantly inhibited LPS-mediated induction of COX-2 expression in both mRNA and protein levels in a concentration-dependent manner. COX-2 enzyme activity was also inhibited in accordance with mRNA and protein levels. Furthermore, curcumin markedly inhibited LPS-induced nuclear factor kappaB (NF-kappaB) and activator protein 1 (AP-1) DNA bindings. These data suggest that curcumin suppresses LPS-induced COX-2 gene expression by inhibiting NF-kappaB and AP-1 DNA bindings in BV2 microglial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037818     DOI: 10.1254/jphs.94.325

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  43 in total

1.  Inhibition of Nod2 signaling and target gene expression by curcumin.

Authors:  Shurong Huang; Ling Zhao; Kihoon Kim; Dong Seok Lee; Daniel H Hwang
Journal:  Mol Pharmacol       Date:  2008-04-15       Impact factor: 4.436

Review 2.  Cancer and diet: How are they related?

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Afsaneh Lavasanifar; Bharat B Aggarwal
Journal:  Free Radic Res       Date:  2011-06-09

3.  Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2.

Authors:  Hua Jiang; Chang-Sheng Deng; Ming Zhang; Jian Xia
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid.

Authors:  Yan-Ting Jian; Guo-Feng Mai; Ji-De Wang; Ya-Li Zhang; Rong-Cheng Luo; Yong-Xin Fang
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

Review 5.  Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer.

Authors:  Shreena J Desai; Ben Prickril; Avraham Rasooly
Journal:  Nutr Cancer       Date:  2018-03-26       Impact factor: 2.900

6.  Oral curcumin supplementation improves fine motor function in the middle-aged rhesus monkey.

Authors:  Tara L Moore; Bethany G E Bowley; Penny L Shultz; Samantha M Calderazzo; Eli J Shobin; Ajay R Uprety; Douglas L Rosene; Mark B Moss
Journal:  Somatosens Mot Res       Date:  2018-02-15       Impact factor: 1.111

7.  Challenging oneself intermittently to improve health.

Authors:  Mark P Mattson
Journal:  Dose Response       Date:  2014-10-20       Impact factor: 2.658

8.  Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC.

Authors:  Jun Ma; Lynetta Phillips; Ying Wang; Tiane Dai; Janine LaPage; Rama Natarajan; Sharon G Adler
Journal:  BMC Complement Altern Med       Date:  2010-11-12       Impact factor: 3.659

9.  Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-κB and AP-1 Signaling Pathways In Vitro.

Authors:  Bin Hui; Liping Zhang; Qinhua Zhou; Ling Hui
Journal:  Neurotox Res       Date:  2017-11-08       Impact factor: 3.911

Review 10.  Neuroprotective effects of curcumin.

Authors:  Greg M Cole; Bruce Teter; Sally A Frautschy
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.